2025年6月2日 周一
Home > Archive>Volume 33, Issue 1, 2025 >85-92
PDF HTML XML Export Cite reminder
Research progress of vascular wall cells in atherosclerosis
Author:
Affiliation:

Department of Cardiology, Changhai Hospital, Naval Military Medical University, Shanghai 200433, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [66]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Atherosclerosis (As) is a chronic inflammatory arterial wall injury process, and vessel wall cells play an important role in the occurrence and development of As. Vascular endothelial cell (VEC) act as a semi-permeable barrier between vascular smooth muscle cell (VSMC) and vascular lumen, and its injury is the initial stage of As. In addition, Through phenotypic transformation, VSMC could transform into many cell phenotype of the plaques, including macrophage, foam cell, mesenchymal stem cell and so on, and these cells further involved in the occurrence of As. Fibroblast is the main component of vascular adventitia,in pathological conditions, fibroblast differentiate into myofibroblast and participate in the occurrence of As. In this article, we will review the involvement of vascular wall cells in the mechanism of As and its potential therapeutic targets for the treatment of As, which provide new therapeutic ideas for As.

    Reference
    [1] BU L L, YUAN H H, XIE L L, et al.New dawn for atherosclerosis:vascular endothelial cell senescence and death.Int J Mol Sci, 3,4(20):15160.
    [2] 于富洋, 杨胜昌, 吉恩生.血管外膜在低氧性血管重塑中的作用.生理学报, 8,0(2):211-216 YU F Y, YANG S C, JI E S.The role of adventitia in hypoxic vascular remodeling.Acta Physiologica Sinica, 8,0(2):211-216.
    [3] DABAGH M, JALALI P, BUTLER P J, et al.Mechanotransmission in endothelial cells subjected to oscillatory and multi-directional shear flow.J R Soc Interface, 7,4(130):20170185.
    [4] CANCEL L M, EBONG E E, MENSAH S, et al.Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model.Atherosclerosis, 6,2:136-146.
    [5] KANG H, YANG J, ZHANG W, et al.Effect of endothelial glycocalyx on water and LDL transport through the rat abdominal aorta.Am J Physiol Heart Circ Physiol, 1,0(4):H1724-H1737.
    [6] WAUTIER J L, WAUTIER M P.Vascular permeability in diseases.Int J Mol Sci, 2,3(7):3645.
    [7] DELGADILLO L F, LOMAKINA E B, KUEBEL J, et al.Changes in endothelial glycocalyx layer protective ability after inflammatory stimulus.Am J Physiol Cell Physiol, 1,0(2):C216-C224.
    [8] PATIL N P, GMEZ-HERNNDEZ A, ZHANG F, et al.Rhamnan sulfate reduces atherosclerotic plaque formation and vascular inflammation.Biomaterials, 2,1:121865.
    [9] SIEVE I, MNSTER-KHNEL A K, HILFIKER-KLEINER D.Regulation and function of endothelial glycocalyx layer in vascular diseases.Vascul Pharmacol, 8,0:26-33.
    [10] NAGY N, FREUDENBERGER T, MELCHIOR-BECKER A, et al.Inhibition of hyaluronan synthesis accelerates murine atherosclerosis:novel insights into the role of hyaluronan synthesis.Circulation, 0,2(22):2313-2322.
    [11] WANG R, WANG M, YE J, et al.Mechanism overview and target mining of atherosclerosis:endothelial cell injury in atherosclerosis is regulated by glycolysis (review).Int J Mol Med, 1,7(1):65-76.
    [12] XU R H, LIU B, WU J D, et al.miR-143 is involved in endothelial cell dysfunction through suppression of glycolysis and correlated with atherosclerotic plaques formation.Eur Rev Med Pharmacol Sci, 6,0(19):4063-4071.
    [13] YANG Q, XU J, MA Q, et al.PRKAA1/AMPKα1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis.Nat Commun, 8,9(1):4667.
    [14] DE BOCK K, GEORGIADOU M, SCHOORS S, et al.Role of PFKFB3-driven glycolysis in vessel sprouting.Cell, 3,4(3):651-663.
    [15] SCHOORS S, DE BOCK K, CANTELMO A R, et al.Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.Cell Metab, 4,9(1):37-48.
    [16] ZHOU L J, LIN W Z, MENG X Q, et al.Periodontitis exacerbates atherosclerosis through Fusobacterium nucleatum-promoted hepatic glycolysis and lipogenesis.Cardiovasc Res, 3,9(8):1706-1717.
    [17] SU Q, WANG Y, YANG X, et al.Inhibition of endoplasmic reticulum stress apoptosis by estrogen protects human umbilical vein endothelial cells through the PI3 Kinase-Akt signaling pathway.J Cell Biochem, 7,8(12):4568-4574.
    [18] GRESELE P, MOMI S, GUGLIELMINI G.Nitric oxide-enhancing or -releasing agents as antithrombotic drugs.Biochem Pharmacol, 9,6:300-312.
    [19] SHEU M L, HO F M, YANG R S, et al.High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway.Arterioscler Thromb Vasc Biol, 5,5(3):539-545.
    [20] FIORELLI S, PORRO B, COSENTINO N, et al.Activation of Nrf2/HO-1 pathway and human atherosclerotic plaque vulnerability:an in vitro and in vivo study.Cells, 9,8(4):356.
    [21] ZHANG J, CAI W, FAN Z, et al.MicroRNA-24 inhibits the oxidative stress induced by vascular injury by activating the Nrf2/Ho-1 signaling pathway.Atherosclerosis, 9,0:9-18.
    [22] ZHANG Q, LIU J, DUAN H, et al.Activation of Nrf2/HO-1 signaling:an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress.J Adv Res, 1,4:43-63.
    [23] OCHOA C D, WU R F, TERADA L S.ROS signaling and ER stress in cardiovascular disease.Mol Aspects Med, 8,3:18-29.
    [24] PIGNATELLI P, MENICHELLI D, PASTORI D, et al.Oxidative stress and cardiovascular disease:new insights.Kardiol Pol, 8,6(4):713-722.
    [25] PAI P Y, CHOU W C, CHAN S H, et al.Epigallocatechin gallate reduces homocysteine-caused oxidative damages through modulation SIRT1/AMPK pathway in endothelial cells.Am J Chin Med, 1,9(1):113-129.
    [26] CHEN H, LU N, XU C, et al.The role of heat shock protein 27 phosphorylation in the proliferation and apoptosis of human umbilical vein endothelial cells induced by visfatin.Microvasc Res, 9,1:30-36.
    [27] ZHAO H, LIU M, LIU H, et al.Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP pathway.Biosci Rep, 0,0(3):BSR20193431.
    [28] WANG Y, SONG X, LI Z, et al.MicroRNA-103 protects coronary artery endothelial cells against H2O2-induced oxidative stress via BNIP3-mediated end-stage autophagy and antipyroptosis pathways.Oxid Med Cell Longev, 0,0:8351342.
    [29] WANG Y, CHE J, ZHAO H, et al.Paeoniflorin attenuates oxidized low-density lipoprotein-induced apoptosis and adhesion molecule expression by autophagy enhancement in human umbilical vein endothelial cells.J Cell Biochem, 9,0(6):9291-9299.
    [30] VION A C, KHELOUFI M, HAMMOUTENE A, et al.Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow.Proc Natl Acad Sci U S A, 7,4(41):E8675-E8684.
    [31] YUAN P, HU Q, HE X, et al.Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis.Cell Death Dis, 0,1(2):141.
    [32] ZHANG X, RAMREZ C M, ARYAL B, et al.Cav-1 (caveolin-1) deficiency increases autophagy in the endothelium and attenuates vascular inflammation and atherosclerosis.Arterioscler Thromb Vasc Biol, 0,0(6):1510-1522.
    [33] WANG J, WANG W N, XU S B, et al.MicroRNA-214-3p:a link between autophagy and endothelial cell dysfunction in atherosclerosis.Acta Physiol (Oxf), 8,2(3):e12973.
    [34] XIAO S, SONG X, ZHENG M, et al.Interleukin-37 ameliorates atherosclerosis by regulating autophagy-mediated endothelial cell apoptosis and inflammation.Int Immunopharmacol, 3,8:110098.
    [35] CHEN P S, WANG K C, CHAO T H, et al.Recombinant thrombomodulin exerts anti-autophagic action in endothelial cells and provides anti-atherosclerosis effect in apolipoprotein E deficient mice.Sci Rep, 7,7(1):3284.
    [36] GALLUZZI L, VITALE I, AARONSON S A, et al.Molecular mechanisms of cell death:recommendations of the nomenclature committee on cell death 2018.Cell Death Differ, 8,5(3):486-541.
    [37] JIA C, CHEN H, ZHANG J, et al.Role of pyroptosis in cardiovascular diseases.Int Immunopharmacol, 9,7:311-318.
    [38] WANG Y, LIU X, SHI H, et al.NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.Clin Transl Med, 0,0(1):91-106.
    [39] KHAN R, RHEAUME E, TARDIF J C.Examining the role of and treatment directed at IL-1β in atherosclerosis.Curr Atheroscler Rep, 8,0(11):53.
    [40] ZHANG Y, LI X, PITZER A L, et al.Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia:beyond inflammation.Antioxid Redox Signal, 5,2(13):1084-1096.
    [41] BORBOREMA M E A, CROVELLA S, OLIVEIRA D, et al.Inflammasome activation by NLRP1 and NLRC4 in patients with coronary stenosis.Immunobiology, 0,5(3):151940.
    [42] PARSAMANESH N, MOOSSAVI M, BAHRAMI A, et al.NLRP3 inflammasome as a treatment target in atherosclerosis:a focus on statin therapy.Int Immunopharmacol, 9,3:146-155.
    [43] LIU Y, TIE L.Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway.BMC Cardiovasc Disord, 9,9(1):279.
    [44] BAI T, LI M, LIU Y, et al.Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell.Free Radic Biol Med, 0,0:92-102.
    [45] ANDREEVA E R, PUGACH I M, OREKHOV A N.Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta.Atherosclerosis, 7,0(1/2):133-142.
    [46] 舒刘芳.血管平滑肌细胞表型转换对动脉粥样硬化的作用研究进展.中国动脉硬化杂志, 8,6(1):99-102.SHU L F.Phenotypic transformation of vascular smooth muscle cells in atherosclerosis.Chin J Arterioscler, 8,6(1):99-102.
    [47] WOO S H, KYUNG D, LEE S H, et al.TXNIP suppresses the osteochondrogenic Switch of vascular smooth muscle cells in atherosclerosis.Circ Res, 3,2(1):52-71.
    [48] GRZESIAK L, AMAYA-GARRIDO A, FEUILLET G, et al.Leucine-rich alpha-2 glycoprotein 1 accumulates in complicated atherosclerosis and promotes calcification.Int J Mol Sci, 3,4(22):16537.
    [49] WEN Y, KONG Y, CAO G, et al.Di-n-butyl phthalate regulates vascular smooth muscle cells phenotypic switching by MiR-139-5p-MYOCD pathways.Toxicology, 2,7:153279.
    [50] YANG C, XIAO X, HUANG L, et al.Role of kruppel-like factor 4 in atherosclerosis.Clin Chim Acta, 1,2:135-141.
    [51] CHEN Y, SU X, QIN Q, et al.New insights into phenotypic switching of VSMCs induced by hyperhomocysteinemia:role of endothelin-1 signaling.Biomed Pharmacother, 0,3:109758.
    [52] CHEN M Y, KE J F, ZHANG Z H, et al.Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability.Atherosclerosis, 1,3:39-47.
    [53] BASATEMUR G L, JRGENSEN H F, CLARKE M C H, et al.Vascular smooth muscle cells in atherosclerosis.Nat Rev Cardiol, 9,6(12):727-744.
    [54] VON DER THSEN J H, VAN VLIJMEN B J, HOEBEN R C, et al.Induction of atherosclerotic plaque rupture in apolipoprotein E－/－ mice after adenovirus-mediated transfer of p53.Circulation, 2,5(17):2064-2070.
    [55] ZHANG Y Y, SHI Y N, ZHU N, et al.Autophagy:a killer or guardian of vascular smooth muscle cells.J Drug Target, 0,8(5):449-455.
    [56] LIU S, JIANG X, CUI X, et al.Smooth muscle-specific HuR knockout induces defective autophagy and atherosclerosis.Cell Death Dis, 1,2(4):385.
    [57] HE C, ZHU H, ZHANG W, et al.7-Ketocholesterol induces autophagy in vascular smooth muscle cells through Nox4 and Atg4B.Am J Pathol, 3,3(2):626-637.
    [58] WANG Z, LIU B, ZHU J, et al.Nicotine-mediated autophagy of vascular smooth muscle cell accelerates atherosclerosis via nAChRs/ROS/NF-κB signaling pathway.Atherosclerosis, 9,4:1-10.
    [59] XU Y J, ZHENG L, HU Y W, et al.Pyroptosis and its relationship to atherosclerosis.Clin Chim Acta, 8,6:28-37.
    [60] WANG R, WU W, LI W, et al.Activation of NLRP3 inflammasome promotes foam cell formation in vascular smooth muscle cells and atherogenesis via HMGB1.J Am Heart Assoc, 8,7(19):e008596.
    [61] ZHENG F, XING S, GONG Z, et al.Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.Mediators Inflamm, 4,4:507208.
    [62] LIU J, WANG Y, LIAO Y, et al.Circular RNA PPP1CC promotes Porphyromonas gingivalis-lipopolysaccharide-induced pyroptosis of vascular smooth muscle cells by activating the HMGB1/TLR9/AIM2 pathway.J Int Med Res, 1,9(3):300060521996564.
    [63] 阮从潇, 李玉洁, 杨庆, 等.血管外膜细胞成分影响动脉粥样硬化发生发展研究概述.中国中药杂志, 3,8(6):791-794.RUAN C X, LI Y J, YANG Q, et al.Effect of adventitia cells on occurrence and development of atherosclerosis.China J Chin Mater Med, 3,8(6):791-794.
    [64] 楚玉峰, 陈闻东, 朱鼎良, 等.RhoA/ROCK通路参与血管紧张素Ⅱ诱导的血管外膜成纤维细胞表型转化.中华高血压杂志, 7,5(6):493-496.CHU Y F, CHEN W D, ZHU D L, et al.RhoA/ROCK signaling pathway is involved in phenotypic differentiation of adventitial fibroblasts induced by angiotensin Ⅱ.Chin J Hypertens, 7,5(6):493-496.
    [65] 李洋, 韩雅玲, 段岩, 等.CREG参与调控血管外膜成纤维细胞表型转化//第14届中国南方国际心血管病学术会议专刊.广州:中华医学会杂志社, 2012:291-292.LI Y, HAN Y L, DUAN Y, et al.CREG participates in regulating the phenotypic transformation of vascular outer membrane fibroblasts//Special Issue of the 14th Southern China International Cardiovascular Disease Conference.Guangzhou:Journal of the Chinese Medical Association, 2012:291-292.
    [66] TIEU B C, JU X, LEE C, et al.Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling.J Vasc Res, 1,8(3):261-272.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

NUERKEZI Abuduhelili, ZHANG Sha, WU Hong. Research progress of vascular wall cells in atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2025,33(1):85-92.

Copy
Share
Article Metrics
  • Abstract:72
  • PDF: 100
  • HTML: 0
  • Cited by: 0
History
  • Received:October 18,2023
  • Revised:March 31,2024
  • Online: January 26,2025
Article QR Code

You are the 52094 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025